Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

NEARs rally and breakout to a one-year high are drawing attention, with traders linking the move to reports that Bitwises NEAR ETF has clearance to list on NYSE Arca and to broader institutional interest. The mood is strongly bullish, though some traders warn of profit-taking, pullbacks, and short-term volatility.

Attention centers on Amarins Phase 3 EMT-2 colorectal-cancer results being presented as an ESMO late-breaking abstract; traders caution that the designation does not signal whether the findings are positive. Discussion also focuses on the LR-EtEPA patent after a USPTO non-final action, with some viewing it as important to a future product or potential sale while others doubt a near-term buyout.

CVS is drawing attention after rebounding from an eight-session slide, with traders citing oversold conditions and bullish chart patterns. Some also point to strong Q2 results and raised full-year guidance as support, while others remain cautious after the stocks prolonged weakness.

Rolls-Royces ongoing share buyback is a key focus, with traders viewing the purchases as potential support for the shares; dividend payments and progress on a possible narrowbody aircraft-engine program are also drawing attention. Despite these bullish themes, some holders are frustrated by recent weakness and question why the stock is not responding more strongly.

DoorDash is drawing attention over New Yorks worker-pay settlement and required oversight, with traders concerned the costs could pressure margins and prompt similar actions elsewhere. The community also debates whether the legal setback is already reflected in the shares, alongside some technical-bounce commentary.

FETs sharp rebound and rising volume have fueled breakout talk, with traders highlighting its autonomous-agent and decentralized-AI focus. Bullish posts see the move as a possible recovery, while skeptics call it a short-lived pump and warn that broader crypto weakness could reverse the gains.

U.S. tariffs on imported drones and components, alongside the push to build domestic drone supply chains, have fueled interest in UMAC as a U.S. drone-parts supplier. Traders are also watching for Pentagon contracts or funding, but debate the delays, valuation, potential dilution, and sharp volatility.

Bitcoin Cashs sharp rally and breakout are driving attention, with traders linking the move to CME futures access and a Grayscale filing. Bulls see room for further gains, while skeptics question the coins utility and whether the momentum will hold.

Air Canadas substantial issuer bid and preliminary repurchase results are the main focus, with traders linking the share-price drop to prorated tendered shares that were not bought back potentially being sold. Some see the reduced share count and continued buybacks as supportive, while others question the abrupt decline and point to fuel costs as a risk.

Positive Phase 2 results for AbCelleras ABCL635 menopause treatment and the planned presentation of more efficacy and safety data are driving attention. Bulls view the results as validation of AbCelleras in-house drug pipeline, while cautious traders note that durability and success in larger Phase 3 trials remain unproven.